Research & Development in
Muttenz

INOFEA AG

Since 2014 · 11–20 empl.

The core activity of INOFEA AG is the development of enzyme-based solutions for the optimized synthesis of high-quality compounds in production processes.

N.E.T. - Network.Enable.Think. GmbH

Since 2017 · 1–10 empl.

N.E.T. - Network.Enable.Think. GmbH provides consulting and implementation services to support clients in developing and realizing ideas. Services include conception and project management, workshops, surveys and interviews, analysis and coordination, organising cross‑industry networking events, and designing workspaces and technology‑oriented solution options.

Perseo pharma AG

Since 2019 · 11–20 empl.

The core activity of Perseo Pharma AG is the development of enzyme replacement therapies for the treatment of metabolic diseases, in particular for rare diseases such as exocrine pancreatic insufficiency, congenital sucrase-isomaltase deficiency and maple syrup urine disease. The company develops innovative therapies based on the enzzen platform technology and focuses on the clinical development of active ingredients for the treatment of these diseases.

Sugar Energy Swiss GmbH

Since 2025 · 1–10 empl.

Sugar Energy Swiss GmbH provides market development, sales and after‑sales services for bio‑based materials and downstream furan derivatives. Its product range includes 5‑HMF, FDCA, PEF and other furan‑based intermediates and products for use in pharmaceuticals, fine chemicals, packaging and feed additives.

Preclin Consulting GmbH

Since 2007 · 1–10 empl.

Preclin Consulting GmbH is a consultancy for toxicology, pathology and non‑clinical safety assessment. Services include preclinical development planning, design and monitoring of toxicology studies (genetic toxicology, safety pharmacology, reproductive and juvenile studies), pathology peer review and report assessment, calculation of human safety factors, and support for non‑clinical regulatory dossiers (e.g. IB, IMPD, CTD sections).

Bloocell Suisse AG

Since 2025 · 1–10 empl.

Bloocell Suisse AG develops and distributes artificial tissue technologies in the field of tissue engineering. The company offers products and solutions for several medical applications, including orthopedics, dentistry, ENT, neurosurgery, plastic and reconstructive surgery, thoracic surgery, and maxillofacial surgery.

Chris Häring Holding AG

Since 2003 · 1–10 empl.

Vanzetti Engineering-Research & Development GmbH

Since 2006 · 1–10 empl.

Hometown Bicycles AG

Since 2015 · 1–10 empl.

WMS Innovation AG

Since 2019 · 1–10 empl.

Zedda Innovation Consulting

Since 2021 · 1–10 empl.

Rennbahn Research Foundation

Since 2022 · 1–10 empl.